Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
Stocks with rising relative strength: Novartis ADR
Anthropic adds Novartis CEO Narasimhan to board of directors (ANTHRO ...
Novartis finalizes US manufacturing and R&D expansion plan | The ...
Novartis misses Q1 estimates as generics hurt sales | FMT
Novartis ‘nears’ deal to acquire Avidity Biosciences for more than $70 ...
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Newsroom | Novartis
Novartis finalizes US manufacturing and R&D expansion plan with seventh ...
Novartis shares fall as Entresto sales weaken | pharmaphorum
Novartis gains key EU, WHO and EMA regulatory nods
Novartis announces expansion of community health programs to close gaps ...
Trump says tariffs prompt Novartis to expand US manufacturing
Novartis Earnings Fall on Slide in Cancer-Drug Sales - WSJ
Novartis Could Upgrade Future Growth Outlook - WSJ
Radioligand Therapy Production in Millburn, NJ | Novartis United States ...
Better Pharma Dividend Stock: Novartis vs. Merck - AOL
Novartis pharmaceuticals will expand in NC with Morrisville facility ...
Novartis Q1 profit down on US generic erosion - Markets - Business Recorder
Drugmaker Novartis begins work on Research Triangle expansion
The FDA Wants to Watch Your Clinical Trial in Real Time • Novartis ...
Novartis Halten von DZ BANK am 28.04.26 | finanzen.ch
Novartis Buy von Deutsche Bank AG am 29.04.26 | finanzen.ch
Novartis fällt über die Patent-Klippe | Börsen-Zeitung
Novartis invertirá 50 mdd en investigación clínica en México- Grupo Milenio
Novartis baut siebte neue Produktionsstätte in den USA
Farmacêutica Novartis compra biotecnológica Excellergy por 1,7 mil milhões
Auslaufen mehrerer Patente beschert Basler Pharmakonzern Novartis ...
L'ex-dirigeant de Novartis André Wyss est le nouveau président des CFF ...
Novartis se dote d'une septième usine aux États-Unis | Zonebourse
Perché Novartis non brinda per le trimestrali, ma AstraZeneca e GSK sì ...
Novartis AG 股票，NOVN 在证券交易所的股票行情 - FIRSTonline
Novartis : la concurrence des génériques pèse sur les résultats du T1 ...
Πτώση πωλήσεων και κερδών για τη Novartis στο πρώτο τρίμηνο λόγω λήξης ...
Las presentaciones de datos de Novartis en la AAAAI y la AAD subrayan ...
Novartis Exceeds Q1 Forecasts, Boosts Outlook as Blockbuster Drug Sales ...
Novartis expects $1 billion savings from lean new operating model ...
Meet Novartis Management 2020 | Novartis
Novartis Logo Transparent
About | Novartis
Novartis 2025: Strengthening foundations and delivering returns ...
Novartis Strategy & Growth Update - YouTube
Novartis Oncology GSK Pharma Completes Deal With Novartis Healthcare
Novartis unveils new plan based on eight multi-billion dollar brands ...
Novartis steps up coronavirus fight as part of new collaboration - SWI ...
Novartis to acquire Regulus in deal for kidney disease drug | BioPharma ...
Novartis Top 10 Products at Jeremy Sanchez blog
Novartis to Invest $23 Billion in US Healthcare Infrastructure Over 5 Years
Novartis reports data from Phase IIIb trial of SMA therapy
Novartis and the Shifting US Drug Pricing Landscape: Strategic ...
Novartis projects +5-6% cc sales CAGR 2025-2030, with long-term growth ...
my presentation on novartis by saru ternimath on Prezi
Novartis sets sights on high-value medicines and US market - SWI ...
Strategy Update: Reimagining Medicine | PDF | Novartis | Clinical Trial
US Senate asks Novartis to shed light on data manipulation allegations ...
2022 Q4 and Full Year Results Presentation & Transcript | Novartis
Savant Capital LLC Buys 4,514 Shares of Novartis AG $NVS
Novartis wins approval for first US biosimilar drug | Fox News
Novartis CEO says U.S. exit from global health programmes to affect ...
Top Novartis cardiac drug to go off patent - The Times of India
Inside Novartis 2021 Integrated Report – The CSR Arena
NOVARTIS | PDF
Novartis to invest $23bn into US-based infrastructure over next five ...
The Novartis Logo History, Colors, Font, And Meaning
Novartis offers solutions to medicine access problem through its access ...
How Novartis Is Transforming Its Structure in 2019
Novartis | PDF
Novartis Report 2024 – PING
Novartis Plans $23 Billion US Buildout as Pharma Faces Pressure From Trump
Novartis | PPTX | Pharmaceutical Industry | Industries
Novartis boss warns US drug pricing reform poses risk to public health
Novartis Steps Up Digital Strategy for AMD Treatments and Patient ...
Oncoshot Works With Novartis To Reform Clinical Trials Management ...
Strategy | Novartis
Novartis CEO Targets 20 Key Drugs as Potential Blockbusters - DCAT ...
💊 Novartis in Healthcare: Revolutionizing Drug Discovery with Data ...
Novartis Chief Eyes Ways To End Higher US Drug Prices:…
Novartis Gains China Approval for Pioneering Cholesterol Drug
Novartis rare disease drug Fabhalta wins FDA nod in IgAN
Novartis Pharma, Rich History, Mission and Values, and 17 Products ...
Novartis strikes deal with UK biotech for up to US$1.7 billion - The ...
How Novartis Empowered Employees To Make Their Ideas Happen
NOVARTIS PHARMA (IMPACT OF MERGERS & ACQUISITIONS) | DOCX
Novartis Invests $23B in U.S. Manufacturing Expansion Amid Trade ...
Novartis ‘Moving as Fast as Possible’ to Fully Manufacture Key Drugs in ...
Novartis options BeiGene anti-cancer therapy in $1 billion deal | Reuters
Novartis’ Q1 sales miss hints at industry’s utilisation of M&A remedies
Novartis, Roche near US drug price deal, Bloomberg News reports | The ...
Novartis’ sales dip as generics pressure intensifies, radioequivalents ...
Novartis-Chef kritisiert die deutsche Gesundheitsreform: «Ein falsches ...
Novartis: Pluvicto wächst 70 Prozent
Schmiergeldklage gegen Novartis: Illegale Zahlungen an Ärzte?
Novartis: Geplagt von Patent-Problemen
Patent-Schock bei Novartis: Entresto bricht ein – Aktie unter Druck ...
Novartis: Deal 2 δισ. δολ. για την εξαγορά της Excellergy | Ειδήσεις ...
Novartis: Vas Narasimhan droht mit Markt-Rückzug von Medikamenten - Blick
2022-04-novartis-new-organizational-model-presentation.pdf
Pharmaceutical Technology
107180804-1674109243972-gettyimages-1088275190-SWITZERLAND_NOVARTIS ...
What’s Novartis’s New Structure?
Novartis: Innovating For The World, From India - Forbes India
Novartis’ Fabhalta is first FDA-cleared oral therapy for PNH | pharmaphorum
What is Next for Novartis? Restructuring on the Way - DCAT Value Chain ...
PPT - Bioethics in Commercial R&D: Balancing Ethics & Innovation at ...
Novartis’s new chief sets sights on ‘productivity revolution’
Novartis' Arogya Parivar program wins award
Πώς χτίστηκε ο μύθος του «Έλληνα Εσκομπάρ» – Από πορτιέρης στη Συγγρού ...
2022-04-novartis-new-organizational-model-presentation.pdf ...
GRAPHIC
MarketLine：诺华公司（NOVARTIS）发展概况、SWOT与财务状况深度分析报告（英文版）.pdf | 先导研报
:max_bytes(150000):strip_icc()/GettyImages-1244662972-6c92522b2e9d48ada3788062940cec51.jpg)
